75
Views
1
CrossRef citations to date
0
Altmetric
Rapid Communication

The occurrence of cerebrovascular atherosclerosis in Alzheimer’s disease patients

, , &
Pages 581-584 | Published online: 24 May 2013

References

  • RoherAEDebbinsJPMalek-AhmadiMCerebral blood flow in Alzheimer’s diseaseVasc Health Risk Manag2012859961123109807
  • AltmanRRutledgeJCThe vascular contribution to Alzheimer’s diseaseClin Sci (Lond)20101191040742120684749
  • KennellySPLawlorBAKennyRABlood pressure and the risk for dementia: a double-edged swordAgeing Res Rev200982617019063999
  • HonjoKBlackSEVerhoeffNPAlzheimer’s disease, cerebrovascular disease, and the β-amyloid cascadeCan J Neurol Sci201239671272823227576
  • ChuLWAlzheimer’s disease: early diagnosis and treatmentHong Kong Med J201218322823722665688
  • HooghiemstraAMEggermontLHScheltensPvan der FlierWMScherderEJExercise and early-onset Alzheimer’s disease: theoretical considerationsDement Geriatr Cogn Dis Extra2012213214522590474
  • GrinbergLTThalDRVascular pathology in the aged human brainActa Neuropathol2010119327729020155424
  • VeglioFPaglieriCRabbiaFBisbocciDBerguiMCerratoPHypertension and cerebrovascular damageAtherosclerosis2009205233134119100549
  • OnyikeCUCerebrovascular disease and dementiaInt Rev Psychiatry200618542343117085361
  • YarchoanMXieSXKlingMACerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementiasBrain2012135Pt 123749375623204143
  • OrsucciDMancusoMIencoECSimonciniCSicilianoGBonuccelliUVascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer’s diseaseCurr Neurovasc Res2013101768023151073
  • SilvestriniMViticchiGFalsettiLThe role of carotid atherosclerosis in Alzheimer’s disease progressionJ Alzheimer’s Dis201125471972621508532
  • PalaciosHHYendluriBBParvathaneniKMitochondrion-specific antioxidants as drug treatments for Alzheimer diseaseCNS Neurol Disord Drug Targets201110214916221222631
  • RocchiAOrsucciDTognoniGCeravoloRSicilianoGThe role of vascular factors in late-onset sporadic Alzheimer’s disease. Genetic and molecular aspectsCurr Alzheimer Res20096322423719519304
  • JichaGAParisiJEDicksonDWAge and apoE associations with complex pathologic features in Alzheimer’s diseaseJ Neurol Sci20082731–2343918653200
  • BhatNRLinking cardiometabolic disorders to sporadic Alzheimer’s disease: a perspective on potential mechanisms and mediatorsJ Neurochem2010115355156220807313
  • BeeriMSRappMSilvermanJMCoronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriersNeurology20066691399140416682673
  • KosunenOTalasniemiSLehtovirtaMRelation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patientsStroke19952657437487740560
  • MorettiRTorrePAntonelloRMManganaroDVilottiCPizzolatoGRisk factors for vascular dementia: hypotension as a key pointVasc Health Risk Manag20084239540218561514
  • WeinsteinGWolfPABeiserASAuRSeshadriSRisk estimations, risk factors, and genetic variants associated with Alzheimer’s disease in selected publications from the Framingham Heart StudyJ Alzheimers Dis201333Suppl 1S439S44522796871
  • CechettoDFHachinskiVWhiteheadSNVascular risk factors and Alzheimer’s diseaseExpert Rev Neurother20088574375018457531
  • RafaelHCerebral atherosclerosis and mild Alzheimer’s diseaseStroke2003348e10612855821
  • PremkumarDRCohenDLHederaPFriedlandRPKalariaRNApolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer’s diseaseAm J Pathol19961486208320958669492
  • MusiekESSabouryBMishraSFeasibility of estimation of brain volume and 2-deoxy-2-(18)F-fluoro-D-glucose metabolism using a novel automated image analysis method: application in Alzheimer’s diseaseHell J Nucl Med201215319019623106049
  • WestmanEMuehlboeckJSSimmonsACombining MRI and CSF measures for classification of Alzheimer’s disease and prediction of mild cognitive impairment conversionNeuroimage201262122923822580170
  • ManookAYousefiBHWilluweitASmall-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer’s diseasePLoS One201273e3131022427802
  • KalbackWEshCCastanoEMAtherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer’s diseaseNeurol Res200426552553915265270